We are live on ! Find out more

14 hedge funds and large institutions have $7.14M invested in BioVie in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1414 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.01% less ownership

Funds ownership: 0.07%0.06% (-0.01%)

4% less capital invested

Capital invested by funds: $7.45M → $7.14M (-$311K)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
14
Holders Change
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
2
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change

BIVI Hedge Fund Activity: Q1 2022 in Review

14 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in BioVie (BIVI) for Q1 2022, worth a combined $7.14M — down 4.2% from $7.45M a quarter earlier.

Fund positioning in BIVI was balanced in Q1 2022: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 3 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $22.2K. The largest seller was Kepos Capital, cutting an estimated $222K.

  • 14 institutional investors held BioVie (BIVI) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $7.14M of BioVie stock for Q1 2022, down 4.2% quarter-over-quarter.
  • 3 funds opened new BioVie positions in Q1 2022 and 3 closed out, a net change of 0 holders.
  • The largest BioVie buyer in Q1 2022 was Geode Capital Management, an estimated $22.2K added.
  • The largest BioVie seller in Q1 2022 was Kepos Capital, an estimated $222K sold.

Based on aggregated 13F filings for Q1 2022.